Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 6, 2021; 9(10): 2409-2418
Published online Apr 6, 2021. doi: 10.12998/wjcc.v9.i10.2409
Published online Apr 6, 2021. doi: 10.12998/wjcc.v9.i10.2409
Table 1 Laboratory values upon admission
| Value | Unit | Normal range | ||
| Glucose | 5.5 | mmol/L | 3.6-6.1 | |
| Urea | H | 8.9 | mmol/L | 2.8-7.5 |
| Sodium | 138 | mmol/L | 135-145 | |
| Potassium | 4.6 | mmol/L | 3.7-4.9 | |
| Creatinine | H | 149 | µmol/L | 44-97 |
| eGFR (CDK-EPI) | 41 | mL/min per 1.73 m2 | ||
| Bilirubin, total | H | 52 | µmol/L | < 17 |
| Bilirubin, direct | H | 33 | µmol/L | < 5 |
| AP | H | 10.72 | µkat/L | < 2.15 |
| AST | H | 1.08 | µkat/L | < 0.58 |
| ALT | H | 1.68 | µkat/L | < 0.74 |
| GGT | H | 10.86 | µkat/L | < 0.94 |
| Amylase | 1.15 | µkat/L | < 1.67 | |
| Lipase | 0.61 | µkat/L | < 1.00 | |
| LDH | H | 5.50 | µkat/L | < 4.13 |
| CRP | H | 63 | mg/L | 0-5 |
| Procalcitonin | H | 0.31 | µg/mL | < 0.24 |
| WBC | 9.4 | 109/L | 4.0-10.0 | |
| RBC | L | 2.04 | 1012/L | 4.50-5.50 |
| Haemoglobin | L | 65 | g/L | 130-170 |
| Haematocrit | L | 0.190 | 1 | 0.400-0.500 |
| MCV | 93.0 | fL | 83.0-101.0 | |
| Platelet count | 349 | 109/L | 150-410 | |
| Prothrombin time | 1.00 | 1 | 0.70-1.30 | |
| INR | 1.00 | < 1.30 | ||
| D-dimer | H | 7904 | µg/L | < 500 |
Table 2 Coagulation tests performed during admission
| Value | Unit | Normal range | ||
| Prothrombin time | 1.00 | 1 | 0.70-1.30 | |
| INR | 1.00 | < 1.30 | ||
| aPTT | H | 92 | s | 25.9-36.6 |
| Fibrinogen | 2.67 | g/L | 1.8-3.5 | |
| Thrombin time | 15.7 | s | 14.0-21.0 | |
| D-dimer | H | 4040 | µg/L | < 500 |
| Factor VIII:C | L | 0.01 | IU/mL | 0.50-1.50 |
| Factor VIII antibodies | H | 30 | BU/mL | 0 |
- Citation: Krašek V, Kotnik A, Zavrtanik H, Klen J, Zver S. Acquired haemophilia in patients with malignant disease: A case report. World J Clin Cases 2021; 9(10): 2409-2418
- URL: https://www.wjgnet.com/2307-8960/full/v9/i10/2409.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i10.2409
